NCRI - The UK Top living with and beyond cance... - CLL Support

CLL Support

22,703 members38,962 posts

NCRI - The UK Top living with and beyond cancer research priorities

Myrddin profile image
1 Reply

By 2030 four million people in the UK will be living with the long-term consequences of cancer, but currently there is very little research on the problems they face and how these can be tackled. To help them live better lives, more focused research is needed.

To determine priorities for research that will help people live better with and beyond cancer, NCRI partnered with the James Lind Alliance on a Priority Setting Partnership. The two-year project involved two UK-wide surveys which attracted more than 3500 responses from patients, carers, and health and social care professionals. From these, we identified 26 key questions and distilled these down to 10 top research priorities.

This is the first time that clear research priorities have been identified in this area. Find out the UK Top living with and beyond cancer research priorities BELOW.

ncri.org.uk/lwbc/?fbclid=Iw...

Written by
Myrddin profile image
Myrddin
To view profiles and participate in discussions please or .
1 Reply
pkguk2 profile image
pkguk2PartnerCLL Support Association

Interesting and much needed research. Thanks for posting

You may also like...

Blood cancers debate in UK Parliament - CLL highlighted

ensure fairer access for patients with blood cancers (rarer cancers). You can read the full debate...

Uk What is the exact SNOMED code for CLL to get priority PCR test kit and letter?

In the continuing saga of trying to get a priority PCR test and letter does anybody know the exact...

CLL / Skin Cancer - getting it checked in the UK

Over 100,000 of the most vulnerable people have not had third jab

\\"Blood Cancer UK said its own support line had repeatedly been contacted over the last two months...

U.S. advisory group lays out detailed recommendations on how to prioritize Covid-19 vaccine

in the tens of millions of doses. Most of the vaccines under development will require two doses per...